Yield10 Bioscience (NASDAQ:YTEN) issued its quarterly earnings data on Tuesday. The specialty chemicals company reported ($0.16) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.16), Fidelity Earnings reports. The business had revenue of $0.22 million for the quarter. Yield10 Bioscience had a negative return on equity of 145.61% and a negative net margin of 1,320.21%.
Shares of NASDAQ YTEN traded down $0.02 during trading on Wednesday, reaching $0.31. The company had a trading volume of 28,698 shares, compared to its average volume of 146,007. The company’s fifty day moving average price is $0.53 and its 200-day moving average price is $0.80. Yield10 Bioscience has a 12 month low of $0.29 and a 12 month high of $1.77. The stock has a market cap of $4.02 million, a P/E ratio of -0.34 and a beta of 3.15. The company has a quick ratio of 3.33, a current ratio of 3.33 and a debt-to-equity ratio of 1.17.
A number of brokerages recently weighed in on YTEN. National Securities restated a “buy” rating and set a $5.00 price objective on shares of Yield10 Bioscience in a research report on Tuesday, August 20th. Zacks Investment Research restated a “hold” rating on shares of Yield10 Bioscience in a research report on Saturday, October 19th. Finally, Aegis reiterated a “buy” rating and issued a $2.00 price target on shares of Yield10 Bioscience in a research report on Tuesday, August 13th.
Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield.
Featured Article: Quick Ratio
Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.